Immunogenicity 12134
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
GLYATL2
Transcript ID
uc009ymq.3
HLA INFO
B*27:02
TCR INFO
No TCR info found!
Full length protein sequence (294 aa)
MLVLH
1
NSQKL
6
QILYK
11
SLEKS
16
IPESI
21
KVYGA
26
IFNIK
31
DKNPF
36
NMEVL
41
VDAWP
46
DYQIV
51
ITRPQ
56
KQEMK
61
DDQDH
66
YTNTY
71
HIFTK
76
APDKL
81
EEVLS
86
YSNVI
91
SWEQT
96
LQIQG
101
CQEGL
106
DEAIR
111
KVATS
116
KSVQV
121
DYMKT
126
ILFIP
131
ELPKK
136
HKTSS
141
NDKME
146
LFEVD
151
DDNKE
156
GNFSN
161
MFLDA
166
SHAGL
171
VNEHW
176
AFGKN
181
ERSLK
186
YIERC
191
LQDFL
196
GFGVL
201
GPEGQ
206
LVSWI
211
VMEQS
216
CELRM
221
GYTVP
226
KYRHQ
231
GNMLQ
236
IGYHL
241
EKYLS
246
QKEIP
251
FYFHV
256
ADNNE
261
KSLQA
266
LNNLG
271
FKICP
276
CGWHQ
281
WKCTP
286
KKYC
291
Mutation Information
DNA mutation:
None
Peptide Range:
186 ~ 210
Mut AA position:
198 (13 in Wild Type peptide)
Alignment
Wild Type:
"ERSLKYIERCLQDFLGFGVLGPEGQ
||||||||||||.||||||||||||
Mutant:
ERSLKYIERCLQNFLGFGVLGPEGQ"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) GLYATL2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay